These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27073018)

  • 21. Vascular endothelium and immune responses: implications for inflammation and angiogenesis.
    Szekanecz Z; Koch AE
    Rheum Dis Clin North Am; 2004 Feb; 30(1):97-114. PubMed ID: 15061570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targets for regulating angiogenesis in the ageing endothelium.
    Ballard VL; Edelberg JM
    Expert Opin Ther Targets; 2007 Nov; 11(11):1385-99. PubMed ID: 18028005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
    Volin MV; Koch AE
    J Interferon Cytokine Res; 2011 Oct; 31(10):745-51. PubMed ID: 21864160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.
    Joosten LA; Abdollahi-Roodsaz S; Dinarello CA; O'Neill L; Netea MG
    Nat Rev Rheumatol; 2016 Jun; 12(6):344-57. PubMed ID: 27170508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging translational approaches to target STAT3 signalling and its impact on vascular disease.
    Dutzmann J; Daniel JM; Bauersachs J; Hilfiker-Kleiner D; Sedding DG
    Cardiovasc Res; 2015 Jun; 106(3):365-74. PubMed ID: 25784694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.
    Kyriakakis E; Cavallari M; Andert J; Philippova M; Koella C; Bochkov V; Erne P; Wilson SB; Mori L; Biedermann BC; Resink TJ; De Libero G
    Eur J Immunol; 2010 Nov; 40(11):3268-79. PubMed ID: 21061446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
    Achek A; Yesudhas D; Choi S
    Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cells: From innocent bystanders to active participants in immune responses.
    Al-Soudi A; Kaaij MH; Tas SW
    Autoimmun Rev; 2017 Sep; 16(9):951-962. PubMed ID: 28698091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors: Activation, signalling and transcriptional modulation.
    De Nardo D
    Cytokine; 2015 Aug; 74(2):181-9. PubMed ID: 25846205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of toll-like receptors by insulin.
    Tilich M; Arora RR
    Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor co-receptors as master regulators of the immune response.
    Di Gioia M; Zanoni I
    Mol Immunol; 2015 Feb; 63(2):143-52. PubMed ID: 24951397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections.
    Opitz B; Eitel J; Meixenberger K; Suttorp N
    Thromb Haemost; 2009 Dec; 102(6):1103-9. PubMed ID: 19967140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence.
    Netea MG; Van der Meer JW; Kullberg BJ
    Clin Microbiol Infect; 2006 May; 12(5):404-9. PubMed ID: 16643515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.